文献速递乳腺MR

abbreviated breast MRI 筛查乳腺癌:3年结果分析

Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
PubMed 文献 · Radiology · 2021-02-23

这项回顾性研究纳入1975名女性共3037次 abbreviated screening MRI,评估连续3年的筛查表现。结果显示癌症检出率、敏感度、特异度等年度间无统计学差异,所有遗漏癌均为淋巴结阴性早期浸润癌且体积更小(中位0.8 cm vs 1.2 cm,P=.01)。

要点

  • abbreviated screening MRI 的年度筛查表现指标在连续3年间保持稳定,无显著差异。
  • 遗漏癌均为淋巴结阴性早期浸润癌,中位大小0.8 cm,小于检出癌的1.2 cm(P=.01)。
  • 筛查间期癌率为每1000次检查0.66例(2/3037)。

关键影像表现/征象

  • 遗漏癌均为淋巴结阴性早期浸润癌,中位大小0.8 cm,检出癌中位大小1.2 cm(P=.01)。
  • 36名女性共发现38个乳腺癌,其中29个经 abbreviated MRI 检出,9个遗漏。
  • 9个遗漏癌中,7个在末次筛查MRI阴性后经其他影像学方法检出,2个为间期癌。

诊断标准与关键数值

  • BI-RADS 3-5类定义为阳性结果,BI-RADS 1-2类定义为阴性结果。
  • 癌症检出率从第1年至第3年为每1000次检查6.9至10.7例。
  • 召回阳性预测值从9.7%(6/62)至15.6%(12/77),活检阳性预测值从31.6%(6/19)至63.2%(12/19)。
  • 敏感度从75.0%(6/8)至80.0%(12/15),特异度从93.5%(807/863)至94.1%(1041/1106)。
  • 异常解读率从7.1%(62/871)至6.9%(77/1121);上述所有指标年度间比较均P>.05。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Data are limited regarding the performance of abbreviated screening breast MRI during consecutive years and the characteristics of breast cancers missed and detected with it. Purpose To assess the longitudinal diagnostic performance of abbreviated screening MRI and to determine whether the screening outcomes of abbreviated MRI differed between yearly time periods for 3 consecutive years. Materials and Methods This retrospective study included 1975 consecutive women who underwent abbreviated screening MRI between September 2015 and August 2018. Breast Imaging Reporting and Data System (BI-RADS) categories 3-5 defined positive results, and BI-RADS categories 1-2 defined negative results. Cancer detection rate (CDR), sensitivity, specificity, positive predictive value (PPV), abnormal interpretation rate (AIR), and interval cancer rate were assessed annually. Yearly performance measures were compared with the Fisher exact test by using the permutation method. Clinical-pathologic and imaging characteristics of the missed and detected cancers were compared by using the Fisher exact test and the Wilcoxon rank sum test. Results A total of 1975 women (median age, 49 years; interquartile range, 44-56 years) underwent 3037 abbreviated MRI examinations over 3 years. CDR (year 1 to year 3, 6.9-10.7 per 1000 examinations), positive predictive value for recall (9.7% [six of 62] to 15.6% [12 of 77]), positive predictive value for biopsy (31.6% [six of 19] to 63.2% [12 of 19]), sensitivity (75.0% [six of eight] to 80.0% [12 of 15]), and specificity (93.5% [807 of 863] to 94.1% [1041 of 1106]) were highest in year 3, and AIR (7.1% [62 of 871] to 6.9% [77 of 1121]) was lowest in year 3. However, all outcome measures did not differ statistically between years 1, 2, and 3 (all P > .05). The interval cancer rate was 0.66 per 1000 examinations (two of 3037). Thirty-eight breast cancers were identified in 36 women; 29 were detected with abbreviated MRI, but nine were missed. Of these, seven were detected with other imaging modalities after negative results at the last screening MRI examination, and two were interval cancers. All missed cancers were node-negative early-stage invasive cancers and were smaller (median size, 0.8 cm vs 1.2 cm; P = .01) than detected cancers. Conclusion Screening outcome measures of abbreviated MRI were sustained without significant differences between 3 consecutive years. All cancers missed at abbreviated MRI were node-negative invasive cancers and tended to be smaller than detected cancers. © RSNA, 2021 See also the editorial by Lee in this issue. Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kwon MR, Choi JS, Won H, et al. Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis. Radiology. 2021. PMID: 33620293. doi:10.1148/radiol.2021202927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。